6-Bromo-2-methylquinoline(CAS: 877-42-9)

6-Bromo-2-methylquinoline (CAS: 877-42-9) is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as an organic compound with potential health hazards. It falls under the European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation and may require specific documentation for transport and storage. Additionally, it is regulated by the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) for safety and environmental considerations.

While 6-Bromo-2-methylquinoline (CAS: 877-42-9) is a specific compound, similar alternatives can be found among various brominated quinoline derivatives. Common substitutes include 4-bromoquinoline and 2-methylquinoline. Other reagents such as 2-benzimidazolinone can also be used in similar synthetic pathways, depending on the desired properties and reactivity.

The market for 6-Bromo-2-methylquinoline (CAS: 877-42-9) is primarily driven by its applications in pharmaceuticals, as a precursor for bioactive compounds, and in the development of new materials. Research trends focus on exploring its potential in drug discovery and the synthesis of novel quinoline-based molecules, with ongoing studies on its biological activity and environmental impact.

Waste containing 6-Bromo-2-methylquinoline (CAS: 877-42-9) should be collected in appropriate chemical waste containers, labeled clearly, and stored in a secure area away from ignition sources. Disposal should be in accordance with local regulations, typically through professional waste disposal services specializing in hazardous waste. Incineration is an effective method for disposal, but it must be done in a controlled and compliant manner to minimize environmental impact.